Cubist Systematic Strategies, LLC Novartis Ag Put Options Transaction History

Cubist Systematic Strategies, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 14, 2023	BUY	$94.73 - $105.13 $246,298 - $273,338	2,600 New	2,600 $264,000
Q1 2023 May 15, 2023	SELL	$80.03 - $92.81 $4.84 Million - $5.62 Million	-60,500 Reduced 53.4%	52,800 $4.86 Million
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $5.15 Million - $6.31 Million	68,200 Added 151.22%	113,300 $10.3 Million
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $2.99 Million - $3.5 Million	40,100 Added 802.0%	45,100 $3.43 Million
Q2 2022 Aug 15, 2022	BUY	$80.52 - $93.75 $402,600 - $468,750	5,000 New	5,000 $423,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.